Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke

Thrombosis Research

Volumn 118, Issue 6, 2006, Pages 671-677

  Park, Moon Ho ^a   Min, Joo Young ^a   Koh, Seong Beom ^a   Kim, Byung Jo ^a   Park, Min Kyu ^a   Park, Kun Woo ^a   Lee, Dae Hie ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

CD14; Helicobacter pylori; Polymorphism; Stroke

Indexed keywords

CD14 ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; SEX RATIO;

AGED; ANTIGENS, CD14; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33750473045     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.11.007     Document Type: Article

References (41)

1. Goldstein L.B., Adams R., Becker K., Furberg C.D., Gorelick P.B., Hademenos G., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 103 (2001) 163-182
2. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
3. Alberts M.J. Genetic aspects of cerebrovascular disease. Stroke 22 (1991) 276-280
4. Muhlestein J.B. Bacterial infections and atherosclerosis. J Investig Med 46 (1998) 396-402
5. Kuvin J.T., and Kimmelstiel C.D. Infectious causes of atherosclerosis. Am Heart J 137 (1999) 216-226
6. Mendall M.A., Goggin P.M., Molineaux N., Levy J., Toosy T., Strachan D., et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71 (1994) 437-439
7. Cave D.R. Transmission and epidemiology of Helicobacter pylori. Am J Med 100 (1996) 12S-17S [discussion 17S-18S]
8. Choi K.W. Current topics on digestive disease in Korea. J Gastroenterol Hepatol 12 (1997) S8-S10
9. Schumann R.R., Rietschel E.T., and Loppnow H. The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol (Berl) 183 (1994) 279-297
10. Sweet M.J., and Hume D.A. Endotoxin signal transduction in macrophages. J Leukoc Biol 60 (1996) 8-26
11. Hubacek J.A., Rothe G., Pit'ha J., Skodova Z., Stanek V., Poledne R., et al. C(-260)->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99 (1999) 3218-3220
12. Baldini M., Lohman I.C., Halonen M., Erickson R.P., Holt P.G., and Martinez F.D. A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20 (1999) 976-983
13. Karhukorpi J., Yan Y., Niemela S., Valtonen J., Koistinen P., Joensuu T., et al. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin Exp Immunol 128 (2002) 326-332
14. Eng H.L., Chen C.H., Kuo C.C., Wu J.S., Wang C.H., and Lin T.M. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection. J Infect Dis 188 (2003) 90-97
15. Ito D., Murata M., Tanahashi N., Sato H., Sonoda A., Saito I., et al. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 31 (2000) 2661-2664
16. Zee R.Y., Bates D., and Ridker P.M. A prospective evaluation of the CD14 and CD18 gene polymorphisms and risk of stroke. Stroke 33 (2002) 892-895
17. Bliss Jr. C.M., Golenbock D.T., Keates S., Linevsky J.K., and Kelly C.P. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun 66 (1998) 5357-5363
18. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1993) 35-41
19. Laheij R.J., Straatman H., Jansen J.B., and Verbeek A.L. Evaluation of commercially available Helicobacter pylori serology kits: a review. J Clin Microbiol 36 (1998) 2803-2809
20. Zhang D.E., Hetherington C.J., Tan S., Dziennis S.E., Gonzalez D.A., Chen H.M., et al. Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem 269 (1994) 11425-11434
21. Shimada K., Miyauchi K., Mokuno H., Watanabe Y., Iwama Y., Shigekiyo M., et al. Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting. Int J Cardiol 94 (2004) 87-92
22. Unkelbach K., Gardemann A., Kostrzewa M., Philipp M., Tillmanns H., and Haberbosch W. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 19 (1999) 932-938
23. Ameriso S.F., Fridman E.A., Leiguarda R.C., and Sevlever G.E. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32 (2001) 385-391
24. Lamb D.J., Eales L.J., and Ferns G.A. Immunization with bacillus Calmette-Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis 143 (1999) 105-113
25. Danesh J., Collins R., and Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet 350 (1997) 430-436
26. Libby P., Egan D., and Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 96 (1997) 4095-4103
27. Markus H.S., and Mendall M.A. Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 64 (1998) 104-107
28. Pasceri V., Cammarota G., Patti G., Cuoco L., Gasbarrini A., Grillo R.L., et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 97 (1998) 1675-1679
29. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312 (1996) 1061-1065
30. Patel P., Mendall M.A., Carrington D., Strachan D.P., Leatham E., Molineaux N., et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311 (1995) 711-714
31. Laurila A., Bloigu A., Nayha S., Hassi J., Leinonen M., and Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 142 (1999) 207-210
32. Xu Q., and Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today 2 (1996) 372-379
33. Grau A.J., Buggle F., Lichy C., Brandt T., Becher H., and Rudi J. Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin. J Neurol Sci 186 (2001) 1-5
34. Heuschmann P.U., Neureiter D., Gesslein M., Craiovan B., Maass M., Faller G., et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study. Stroke 32 (2001) 2253-2258
35. Arboix A., and Marti-Vilalta J.L. New concepts in lacunar stroke etiology: the constellation of small-vessel arterial disease. Cerebrovasc Dis 17 Suppl 1 (2004) 58-62
36. Koenig W., Khuseyinova N., Hoffmann M.M., Marz W., Frohlich M., Hoffmeister A., et al. CD14 C(-260)->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 40 (2002) 34-42
37. Amar J., Ruidavets J.B., Sollier C.B., Bongard V., Boccalon H., Chamontin B., et al. CD14 C(- 260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J Hypertens 22 (2004) 1523-1528
38. Lichy C., Meiser H., Grond-Ginsbach C., Buggle F., Dorfer C., and Grau A. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population. J Neurol 249 (2002) 821-823
39. Karhukorpi J., Yan Y., Niemela S., Valtonen J., Koistinen P., Joensuu T., et al. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin Exp Immunol 128 (2002) 326-332
40. Cremonini F., Gabrielli M., Gasbarrini G., Pola P., and Gasbarrini A. The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis. Atherosclerosis 173 (2004) 253-259
41. Kim K.C., Park H.J., Lee H.W., Jung J.K., Chung J.P., Lee K.S., et al. Relation of serum gastrin and pepsinogen levels to serologic recognition of CagA and VacA in Helicobacter pylori infection. Korean J Gastroenterol 29 (1997) 25-34